Articles liés à Degradation Study and Impurity Profiling of Some Marketed...

Degradation Study and Impurity Profiling of Some Marketed Drugs: Brinzolamide, Cilnidipine, Loteprednol Etabonate - Couverture souple

Behera, Chinmaya Chidananda; Dev, Asish

 
9786202922678: Degradation Study and Impurity Profiling of Some Marketed Drugs: Brinzolamide, Cilnidipine, Loteprednol Etabonate

Synopsis

Detection, quantification, and control of impurities in drug and drug products have become unambiguous necessities as per the new Regulatory guidelines, predominantly by the International Conference on Harmonization (ICH) recommends routine analysis of all impurities ≥ 0.1% level through suitable analytical methods. So, it was essential to determine the impurities present in Brinzolamide, Cilnidipine and Loteprednol to guarantee its purity, potency and safety in the pharmaceutical products.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.